Postural Correctors & Activity Trackers in Total Knee Replacement Rehab
Launched by RIPHAH INTERNATIONAL UNIVERSITY · Mar 10, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how two types of devices, postural correctors and activity trackers, can help people recover after total knee replacement surgery. The study aims to see if using a postural corrector can improve knee function and whether an activity tracker can help monitor and boost rehabilitation activities. The researchers are also interested in how these devices might help manage pain during recovery.
To participate in this trial, you need to be between 40 and 60 years old and have had a total knee replacement surgery recently (within the last month). Both men and women can join, as long as they are using commercially available devices that can be worn. If you have any other health issues or have had surgery more than a month ago, you won’t be eligible for this study. Participants will be able to try out these devices while receiving support for their recovery process. This trial is not yet recruiting participants, but it aims to provide valuable insights into improving rehabilitation after knee surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Participants who fall in this category will be included in the study.
- • Commercially available devices
- • Post-operative total knee replacement
- • Males and females
- • Age 40 to 60 years
- Exclusion Criteria:
- • Participants who fall in this category will be excluded from the study.
- • Non wearable devices
- • Patient had been through surgery more than 1 month
- • Patients with any other disorder or disease
About Riphah International University
Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Mānsehra, Kpk, Pakistan
Patients applied
Trial Officials
Ayesha Sadiq, MSPT (OMPT)
Principal Investigator
Riphah International University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported